CALML3 and in situ carcinoma: A strong reduction (or complete lack) of CALML3 immunostaining was seen in invasive squamous cell carcinoma compared to both benign tissue and dysplasia/CIS tissue (Figures 2 and 3), although in low-grade invasive squamous cell carcinoma, keratin pearls did illustrate mild immunoreactivity.